R&D Blueprint
The R&D Blueprint is a global strategy and preparedness plan that allows the rapid activation of research and development activities during epidemics. Its aim is to fast-track the availability of effective tests, vaccines and medicines that can be used to save lives and avert large scale crises.

Filoviruses


Filoviruses are a group of zoonotic pathogens, members of the Filoviridae family, which cause severe, often fatal illness in humans. This family includes medically important pathogens such as Ebola virus (EBOV-formerly Zaire), Marburg virus (MARV), Sudan virus (SUDV), and Bundibugyo virus (BDBV).

Ebola virus (EBOV) first appeared in 1976 in two simultaneous outbreaks, one in what is now, Nzara, South Sudan, and the other in Yambuku, Democratic Republic of the Congo. The latter occurred in a village near the Ebola River, from which the disease takes its name. Marburg virus (MARV) was first identified during an outbreak in 1967, when laboratory workers in Marburg and Frankfurt, Germany and Belgrade, Yugoslavia (what is now Serbia) were infected with a previously unknown infectious agent. Sudan virus (SUDV) was first reported in southern Sudan in June 1976. Since then, the virus has emerged periodically and up to now seven outbreaks caused by SUDV have been reported in central Africa. Bundibugyo virus (BDBV) was first identified in 2007 when a viral hemorrhagic fever outbreak began in the Bundibugyo and Kikyo townships of Bundibugyo District in western Uganda. Three outbreaks have been reported so far, in 2007–2008, 2012 and 2026. The 2026 BDBV outbreak in the Democratic Republic of the Congo, with cross-border spread to Uganda is the largest recorded to date.

Since they were first recognized, these filoviruses have caused regular disease outbreaks in Africa, each affecting limited numbers of people. However, the 2014–2016 outbreak in West Africa, the largest and most complex Ebola outbreak ever with over 11 000 deaths, demonstrated that filoviruses represent a very serious public health threat.

 

R&D Roadmaps

R&D roadmaps are key documents to better understand current and future health threats and identify effective health technologies to save lives.

 


News and Agenda


 

Latest news

 


Technical areas of work


 

Landscapes

Scientific consultations

Outbreak preparedness achievements

Peer-review publications

Show less Show more